← Open Payments lookup

DAVID OGAMI: Open Payments

NPI 1699841809 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$943 in 23 payments from 4 companies in 2025. Trend: 2023 $616 · 2024 $895 · 2025 $943

Food & beverage: $943
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$547
E.R. Squibb & Sons, L.L.C.3$225
Alkermes, Inc.3$90
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$81

Products named: INGREZZA, COBENFY, ARISTADA, CAPLYTA.

Industry payments across CA — which companies pay providers there.